Monday, August 31, 2026
ExploreSearch
Via News
MarketIndexes

CBOE Bullish Momentum With A 24% Rise In The Last 21 Sessions

ViaNews Editorial Team

February 21, 2024

CBOE Bullish Momentum With A 24% Rise In The Last 21 Sessions

(VIANEWS) - CBOE (VIX) has been up by 24.46% for the last 21 sessions. At 06:08 EST on Wednesday, 21 February, CBOE (VIX) is $15.62.

Regarding CBOE's yearly highs and lows, it's 0.58% up from its 52-week low and 55.44% down from its 52-week high.

Volatility

CBOE's last week, last month's, and last quarter's current intraday variation average was 2.65%, 0.87%, and 3.34%, respectively.

CBOE's highest amplitude of average volatility was 3.97% (last week), 3.97% (last month), and 3.34% (last quarter), respectively.

Index Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CBOE's is considered to be oversold (<=20).

News about

  • Nasdaq 100 forecast: continues to look bullish despite holiday - 20 February 2024. According to DailyForex on Tuesday, 20 February, "We might see a somewhat deeper decline if we manage to breach below the 16,950 mark, but I would never short the NASDAQ 100 at this point. "

More news about CBOE (VIX).

Categories

MarketIndexes

Tags

IndexWorld IndicesVIXIndicesCBOEPrice UpINDICES Price UpIndex Now
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com